home / stock / hcwb / hcwb quote
Last: | $0.621213 |
---|---|
Change Percent: | 3.23% |
Open: | $0.6 |
Close: | $0.621213 |
High: | $0.63 |
Low: | $0.6 |
Volume: | 5,693 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.621213 | $0.6 | $0.621213 | $0.63 | $0.6 | 5,693 | 07-05-2024 |
$0.62 | $0.62 | $0.62 | $0.629 | $0.62 | 2,159 | 07-04-2024 |
$0.62 | $0.62 | $0.62 | $0.629 | $0.62 | 2,159 | 07-03-2024 |
$0.62 | $0.6499 | $0.62 | $0.65 | $0.6 | 24,050 | 07-02-2024 |
$0.65 | $0.625 | $0.65 | $0.7699 | $0.625 | 14,044 | 07-01-2024 |
$0.647 | $0.669 | $0.647 | $0.6781 | $0.62 | 11,246 | 06-28-2024 |
$0.6401 | $0.74 | $0.6401 | $0.74 | $0.6109 | 58,072 | 06-27-2024 |
$0.7428 | $0.7406 | $0.7428 | $0.8 | $0.7139 | 10,472 | 06-26-2024 |
$0.787 | $0.778 | $0.787 | $0.849999 | $0.71 | 52,107 | 06-25-2024 |
$0.8002 | $0.874951 | $0.8002 | $1.16 | $0.75 | 399,550 | 06-24-2024 |
$0.7229 | $0.98 | $0.7229 | $1.02 | $0.7229 | 17,031 | 06-21-2024 |
$1 | $1 | $1 | $1.0302 | $0.9305 | 6,307 | 06-20-2024 |
$1.02 | $1.04 | $1.02 | $1.1 | $1.02 | 5,559 | 06-19-2024 |
$1.02 | $1.04 | $1.02 | $1.1 | $1.02 | 5,559 | 06-18-2024 |
$1.02 | $1.1 | $1.02 | $1.1 | $1 | 13,594 | 06-17-2024 |
$1.12 | $1.04 | $1.12 | $1.12 | $1.04 | 3,121 | 06-14-2024 |
$1.117 | $1.16 | $1.117 | $1.2158 | $1.0637 | 11,411 | 06-13-2024 |
$1.13 | $1.07 | $1.13 | $1.1554 | $1.0632 | 4,825 | 06-12-2024 |
$1.07 | $1 | $1.07 | $1.1 | $1 | 12,664 | 06-11-2024 |
$1.01 | $1.004 | $1.01 | $1.0799 | $1.004 | 11,278 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
MIRAMAR, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link be...
MIRAMAR, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link ...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...